Biotechnology

NovAccess Global, Inc. CEO Interviewed On MoneyTV

September 15, 2021 9:00 AM

CLEVELAND, OH / ACCESSWIRE / September 15, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) announced Dr. Dwain Irvin's interview on MoneyTV aired on September 11, 2021. MoneyTV has been in the business for 25 years, reaching 200 million homes in 75 countries. Dr. Dwain Irvin's interview can be watched here. https://novaccessglobal.com/ Dr. Dwain Irvin was interviewed by Don Baillargeon, a broadcast industry veteran of more than 30 years. Don...

Read more

Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021

September 15, 2021 8:05 AM

Conference call with live video webcast to be held on Tuesday, September 21st at 4:30 p.m. ET IRVINE, CA / ACCESSWIRE / September 15, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a developer of medical devices that restore cardiac and vascular health, today announced that Hancock Jaffe management will host a corporate update conference call with a live video webcast on Tuesday, September 21, 2021 at...

Read more

DiviTum(R)TKa Results from SWOG Study Published in Clinical Cancer Research

September 15, 2021 2:20 AM

UPPSALA, SE / ACCESSWIRE / September 15, 2021 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer diagnostics, today announces that DiviTum®TKa results from an analysis of samples from the large SWOG S0226 study have been published in the highly ranked peer-reviewed scientific journal Clinical Cancer Research, published by the American Association for Cancer Research (AACR). The strong results support using...

Read more

Black Bird Biotech Announces First Sales of Disruptive Plant-Based MiteXstreamTM Biopesticide, Prepares for Fourth Quarter Marketing Push Within Cannabis Industry

September 14, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / September 14, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that it had achieved the first sales of its game-changing biopesticide, MiteXstreamTM, as it accelerates its planned fourth quarter sales and marketing efforts that are intended to bring much-needed crop protection to the dynamic cannabis industry, one that is expected to grow to...

Read more

Promising DiviTumTKa Results from BioItaLEE Study Presented at ESMO

September 14, 2021 2:20 AM

UPPSALA, SE / ACCESSWIRE / September 14, 2021 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer diagnostics, today announces that DiviTumTKa results from the large BioItaLEE study will be presented as a poster during the European Society for Medical Oncology (ESMO) meeting 16 to 21 September 2021. The results strengthen the potential of DiviTum ® TKa as a treatment monitoring devise for CDK4/6 inhibitor...

Read more

Applied UV Continues International Expansion with Airocide(R) Installation in South Korean Schools

September 13, 2021 8:30 AM

Installations in nearly 100 school dedicated observation rooms Airocide® technology helps schools reopen safely and allow for the safe return to campus MOUNT VERNON, NY / ACCESSWIRE / September 13, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air...

Read more

Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference

September 13, 2021 8:00 AM

AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in Lake Street's 5th Annual Best Ideas Growth Conference. September 14-15, 2021 Lake Street's 5th Annual Best Ideas Growth Conference Management teams from over 100 dynamic small-cap publicly...

Read more

Oncology Pharma, Inc. Has Received the Committed Funding to Perform All Necessary IND-Enabling Preclinical Work for Its First Lead Candidate, a Dactinomycin Nanoemulsion Drug Product

September 13, 2021 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / September 13, 2021 / Oncology Pharma, Inc. (OTC PINK:ONPH). In keeping with management's commitment to continue implementation of Oncology Pharma's ("the Company") capital formation plan, the Company has obtained, received and segregated all funds necessary to execute the first phase of the development project of a nanoemulsion of dactinomycin, with the initial tranche released as scheduled. Management of...

Read more

Biovica Provides Update on FDA Application Process

September 13, 2021 2:30 AM

UPPSALA, SE / ACCESSWIRE / September 13, 2021 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer diagnostics, today announced that the company's expected timeline for its updated 510(k)-application to the US Food and Drug Administration (FDA) has been prolonged due to delay in response from FDA. As Biovica is still waiting for required feedback from the FDA the company has not been able to submit its updated...

Read more

Applied UV to Present at the Virtual H.C. Wainwright Global Investor Conference

September 10, 2021 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / September 10, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that Q Saeed, CEO of Applied UV, will present at the virtual H.C. Wainwright...

Read more

Viewpoint Molecular Targeting(TM) Receives FDA Clearance of Investigational New Drug Application for Phase 1 Imaging Study for VMT-a-NET for Neuroendocrine Tumors

September 9, 2021 10:00 AM

VMT-𝛼-NET Phase 1 imaging study to be followed by Phase 1/2a therapy study for the treatment of neuroendocrine tumors being conducted at the University of Iowa Preclinical efficacy results demonstrated VMT-𝛼-NET to significantly inhibit tumor growth and improve survival compared to untreated controls VMT-𝛼-NET imaging study provisional results expected in Q4 2021 CORALVILLE, IA / ACCESSWIRE / September 9, 2021 / Viewpoint Molecular Targeting,...

Read more

Ichor Therapeutics Rebrands as Ichor Life Sciences, Focuses on Contract Research Work and Strategic Programs

September 9, 2021 9:00 AM

LAFAYETTE, NY / ACCESSWIRE / September 9, 2021 / Ichor Therapeutics is now known as Ichor Life Sciences. The new name reflects Ichor Life Sciences' emphasis on delivering premium preclinical contract research and custom programs in discovery through pharmacology from its R&D facilities in LaFayette and Potsdam, both located in the Finger Lakes intellectual corridor of upstate New York. Ichor Life Sciences services customers in numerous...

Read more

Xenetic Biosciences, Inc. Receives Notice of Allowance for XCART(TM) Patent

September 9, 2021 8:05 AM

Allowance bolsters intellectual property portfolio for differentiated personalized CAR T platform technology, XCART FRAMINGHAM, MA / ACCESSWIRE / September 9, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today announced the United States Patent and...

Read more

Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences

September 9, 2021 8:00 AM

BOSTON, MA / ACCESSWIRE / September 9, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced that members of the management team will participate in the following upcoming investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference...

Read more

Lexaria to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 9, 2021 7:05 AM

KELOWNA, BC / ACCESSWIRE / September 9, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces today that Chairman & CEO Chris Bunka will present at the 23rd Annual H.C. Wainwright Global Investment Conference which is being held virtually from September 13-15, 2021. Mr. Bunka will provide an overview of the Company's latest news and updates which will...

Read more

Edesa Biotech to Present at the H.C. Wainwright Global Investment Conference

September 9, 2021 7:00 AM

TORONTO, ON / ACCESSWIRE / September 9, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that Dr. Par Nijhawan, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually from September 13 to 15, 2021. Dr. Nijhawan is expected to provide an overview of Edesa's business and...

Read more

BioLargo to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021

September 8, 2021 8:30 AM

WESTMINSTER, CA / ACCESSWIRE / September 8, 2021 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The conference is being held virtually on September 13-15, 2021. President and CEO of BioLargo Dennis Calvert will present on the company's cleantech products and services, such as its newly launched...

Read more

Applied UV Continues Global Expansion with Airocide(R) Installations in Vietnam

September 8, 2021 8:30 AM

Son Tay Hospital and the National Institute of Food Control to install Airocide® technology to protect patients, visitors and staff MOUNT VERNON, NY / ACCESSWIRE / September 8, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy...

Read more

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 8, 2021 8:00 AM

FRAMINGHAM, MA / ACCESSWIRE / September 8, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today announced that Jeffrey F. Eisenberg, Chief Executive Officer of Xenetic will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking...

Read more

Viewpoint Molecular Targeting(R) to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 8, 2021 8:00 AM

CORALVILLE, IA / ACCESSWIRE / September 8, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents, today announced that Frances L. Johnson MD, Chief Executive Officer and Co-Founder of Viewpoint, will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference...

Read more